0001181431-14-033367.txt : 20141002 0001181431-14-033367.hdr.sgml : 20141002 20141002175847 ACCESSION NUMBER: 0001181431-14-033367 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140930 FILED AS OF DATE: 20141002 DATE AS OF CHANGE: 20141002 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Horizon Pharma plc CENTRAL INDEX KEY: 0001492426 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 272179987 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ADELAIDE CHAMBERS STREET 2: PETER STREET CITY: DUBLIN STATE: L2 ZIP: 8 BUSINESS PHONE: 011-353-1-649-8521 MAIL ADDRESS: STREET 1: ADELAIDE CHAMBERS STREET 2: PETER STREET CITY: DUBLIN STATE: L2 ZIP: 8 FORMER COMPANY: FORMER CONFORMED NAME: HORIZON PHARMA, INC. DATE OF NAME CHANGE: 20100520 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DE VAERE ROBERT J CENTRAL INDEX KEY: 0001240116 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35238 FILM NUMBER: 141137813 MAIL ADDRESS: STREET 1: C/O HORIZON PHARMA, INC STREET 2: 1033 SKOKIE BLVD, SUITE 355 CITY: NORTHBROOK STATE: IL ZIP: 60062 4 1 rrd416999.xml X0306 4 2014-09-30 1 0001492426 Horizon Pharma plc HZNP 0001240116 DE VAERE ROBERT J C/O HORIZON PHARMA PLC ADELAIDE CHAMBERS, PETER STREET DUBLIN, IRELAND L2 8 IRELAND 0 1 0 0 EVP & CFO Ordinary Shares 2014-09-30 4 A 0 112166 0 A 206456 D Ordinary Shares 2014-09-30 4 S 0 51942 12.28 D 154514 D Fully vested restricted stock units issued on the Separation Date as defined in that certain Executive Employment and Transition Agreement dated June 17, 2014. Includes 23,467 shares of the Company's ordinary shares acquired pursuant to an employee stock purchase program. Reflects restricted stock units surrendered via a net settlement to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit. /s/ Paul W. Hoelscher, Attorney-in-Fact 2014-10-02